Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Prognostic value of red cell distribution width and echocardiographic parameters in patients with pulmonary embolism.

Pehlivanlar Küçük M, Öztuna F, Abul Y, Özsu S, Kutlu M, Özlü T.

Adv Respir Med. 2019;87(2):69-76. doi: 10.5603/ARM.2019.0012.

2.

[Causes of mediastinal/hilar granulomatous lymphadenitis].

Erbay M, Özsu S, Ayaydın Mürtezaoğlu ES, Türkyılmaz A, Özçelik N, Bülbül Y, Ersöz Ş.

Tuberk Toraks. 2018 Sep;66(3):212-216. doi: 10.5578/tt.67018. Turkish.

3.

[Lupus-like syndrome in patients treated with anti-TNF-α factors].

Şentürk E, Özsu S, Çapkın E, Türkyilmaz A.

Tuberk Toraks. 2018 Mar;66(1):72-75. doi: 10.5578/tt.46502. Turkish.

4.

[A rare case: Kikuchi-Fujimoto disease].

Pehlivanlar Küçük M, Bektaş Aksoy H, Özsu SS, Çobanoğlu Ü, Özlü T.

Tuberk Toraks. 2017 Dec;65(4):337-341. doi: 10.5578/tt.40395. Review. Turkish.

5.

Syncope as a subject of the risk assessment of pulmonary thromboembolism to be used for: A cross-sectional study.

Ozyurt S, Ozsu S, Erbay M, Oztuna F, Gumus A, Sahin U.

Clin Respir J. 2018 Jun;12(6):2136-2140. doi: 10.1111/crj.12784. Epub 2018 Mar 26.

PMID:
29498800
6.

Does the Incidence and Mortality of Pulmonary Thromboembolism Change Over the Years?

Özsu SS, Durmuş ZG, Coşkuner MB, Bülbül Y, Öztuna F, Özlü T.

Turk Thorac J. 2017 Jul;18(3):78-81. doi: 10.5152/TurkThoracJ.2017.16050. Epub 2017 Jul 1.

7.

Prognostic Value of Uric Acid for Pulmonary Thromboembolism.

Ozsu S, Çoşar AM, Aksoy HB, Bülbül Y, Oztuna F, Karahan SC, Ozlu T.

Respir Care. 2017 Aug;62(8):1091-1096. doi: 10.4187/respcare.05433. Epub 2017 Jun 20.

8.

[Inflammatory bowel disease and pulmonary embolism: Because of 3 cases].

Abanoz B, Coşar AM, Erbay M, Özsu S, Bülbül Y.

Tuberk Toraks. 2016 Dec;64(4):310-314. Review. Turkish.

9.

Prognostic importance of central thrombus in hemodynamically stable patients with pulmonary embolism.

Senturk A, Ozsu S, Duru S, Cakır E, Ulaslı SS, Demirdogen E, Kayhan S, Guzel A, Yakar F, Berk S.

Cardiol J. 2017;24(5):508-514. doi: 10.5603/CJ.a2017.0021. Epub 2017 Mar 1.

10.

Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model.

Ozsu S.

Eur Respir J. 2017 Jan 11;49(1). pii: 1601500. doi: 10.1183/13993003.01500-2016. Print 2017 Jan. No abstract available.

11.

Classification of high-risk with cardiac troponin and shock index in normotensive patients with pulmonary embolism.

Ozsu S, Erbay M, Durmuş ZG, Ozlu T.

J Thromb Thrombolysis. 2017 Feb;43(2):179-183. doi: 10.1007/s11239-016-1443-3.

PMID:
27800569
12.

The Significance of the Relative Lymphocyte Count as an Independent Predictor of Cardiovascular Disease in Patients with Obstructive Sleep Apnea Syndrome.

Altunayoglu Cakmak V, Ozsu S, Gulsoy A, Akpinar R, Bulbul Y.

Med Princ Pract. 2016;25(5):455-60. doi: 10.1159/000447697. Epub 2016 Jun 20.

13.

The value of signal peptide-CUB-EGF domain-containing protein-1 (SCUBE1) in the diagnosis of pulmonary embolism: a preliminary study.

Turkmen S, Sahin A, Gunaydin M, Sahin S, Mentese A, Turedi S, Karahan SC, Ozsu S, Gunduz A.

Acad Emerg Med. 2015 Aug;22(8):922-6. doi: 10.1111/acem.12721. Epub 2015 Jul 22.

14.

[Treatment and diagnosis of pulmonary embolism in pregnancy].

Özsu S, Uzun O.

Tuberk Toraks. 2015 Jun;63(2):132-9. Review. Turkish.

15.

A cost-effective method for obtaining standard platelet-rich plasma.

Kececi Y, Ozsu S, Bilgir O.

Wounds. 2014 Aug;26(8):232-8.

PMID:
25860639
16.

[A newly-defined entity: combined pulmonary fibrosis and emphysema syndrome].

Özçelik N, Özsu S.

Tuberk Toraks. 2015;63(1):48-52. Review. Turkish.

17.

Value of Cardiac Troponin and sPESI in Treatment of Pulmonary Thromboembolism at Outpatient Setting.

Ozsu S, Bektas H, Abul Y, Ozlu T, Örem A.

Lung. 2015 Aug;193(4):559-65. doi: 10.1007/s00408-015-9727-5. Epub 2015 Apr 4.

PMID:
25840529
18.

Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?

Senturk A, Ucar EY, Berk S, Ozlu T, Altınsoy B, Dabak G, Cakır E, Kadıoglu EE, Sen HS, Ozsu S; TUPEG Study Investigators.

Clin Appl Thromb Hemost. 2016 May;22(4):395-9. doi: 10.1177/1076029614564863. Epub 2015 Jan 27.

PMID:
25630985
19.

A Rare Cause of Chylothorax: Hennekam Syndrome.

Bektaş H, Bülbül Y, Özsu S, Özlü T.

Turk Thorac J. 2015 Jan;16(1):33-35. doi: 10.5152/ttd.2014.3988. Epub 2014 Nov 5.

20.

Diagnostic value of suPAR in differentiating noncardiac pleural effusions from cardiac pleural effusions.

Ozsu S, Oztuna F, Mentese A, Abul Y, Ozlu T.

Clin Respir J. 2016 Jan;10(1):61-6. doi: 10.1111/crj.12186. Epub 2014 Aug 4.

PMID:
25043397
21.

Combination and comparison of two models in prognosis of pulmonary embolism: results from TUrkey Pulmonary Embolism Group (TUPEG) study.

Ozsu S, Ozlu T, Sentürk A, Uçar EY, Kırkıl G, Kadıoğlu EE, Altınsoy B, Saylan B, Selimoğlu HŞ, Dabak G, Tutar N, Uysal A; TUPEG Study Investigators.

Thromb Res. 2014 Jun;133(6):1006-10. doi: 10.1016/j.thromres.2014.02.032. Epub 2014 Mar 19.

PMID:
24690480
22.

Red cell distribution width: a new predictor for chronic thromboembolic pulmonary hypertension after pulmonary embolism.

Abul Y, Ozsu S, Korkmaz A, Bulbul Y, Orem A, Ozlu T.

Chron Respir Dis. 2014 May;11(2):73-81. doi: 10.1177/1479972314525057. Epub 2014 Mar 4.

PMID:
24595892
23.

Prognostic value of red cell distribution width in patients with sarcoidosis.

Ozsu S, Ozcelik N, Oztuna F, Ozlu T.

Clin Respir J. 2015 Jan;9(1):34-8. doi: 10.1111/crj.12101. Epub 2014 Feb 17.

PMID:
24405971
24.

Chronic thromboembolic pulmonary hypertension: Medical treatment.

Ozsu S, Cinarka H.

Pulm Circ. 2013 Apr;3(2):341-4. doi: 10.4103/2045-8932.114761. Review.

25.

Predictive value of troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism.

Ozsu S, Abul Y, Orem A, Oztuna F, Bulbul Y, Yaman H, Ozlu T.

Multidiscip Respir Med. 2013 May 28;8(1):34. doi: 10.1186/2049-6958-8-34.

26.

Carbonic anhydrase IX in the prediction of right ventricular dysfunction in patients with hemodynamically stable acute pulmonary embolism.

Abul Y, Ozsu S, Mentese A, Durmus I, Bektas H, Pehlivanlar M, Turan OE, Sumer A, Orem A, Ozlu T.

Clin Appl Thromb Hemost. 2014 Nov;20(8):838-43. doi: 10.1177/1076029613486540. Epub 2013 Apr 23.

PMID:
23613041
27.

Prediction of right ventricular dysfunction from radiographic estimates of right descending pulmonary artery in hemodynamically stable pulmonary embolism patients.

Abul Y, Ozsu S, Karakurt S, Ozben B, Durmus I, Toprak A, Ozlu T, Celikel T.

Cardiol J. 2013;20(2):184-9. doi: 10.5603/CJ.2013.0032.

28.

Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.

Ozsu S, Abul Y, Mentese A, Bektas H, Uzun A, Ozlu T, Porcel JM.

Respirology. 2013 May;18(4):657-62. doi: 10.1111/resp.12038.

PMID:
23286371
29.

Prognostic value of red cell distribution width in patients with pulmonary embolism.

Ozsu S, Abul Y, Gunaydin S, Orem A, Ozlu T.

Clin Appl Thromb Hemost. 2014 May;20(4):365-70. doi: 10.1177/1076029612464901. Epub 2012 Nov 8.

PMID:
23144178
30.

Relationship between cardiac troponin-T and right ventricular Tei index in patients with hemodynamically stable pulmonary embolism: an observational study.

Özsu S, Kırış A, Bülbül Y, Öztuna F, Karaman K, Kutlu M, Özlü T.

Anadolu Kardiyol Derg. 2012 Dec;12(8):659-65. doi: 10.5152/akd.2012.218. Epub 2012 Sep 11.

31.

[Prognostic role of biomarkers and right ventricular dysfunction in pulmonary embolism].

Özsu S, Özlü T.

Tuberk Toraks. 2012;60(1):86-91. Review. Turkish.

32.

Red cell distribution width in patients with obstructive sleep apnea syndrome.

Ozsu S, Abul Y, Gulsoy A, Bulbul Y, Yaman S, Ozlu T.

Lung. 2012 Jun;190(3):319-26. doi: 10.1007/s00408-012-9376-x. Epub 2012 Feb 7.

PMID:
22310880
33.

Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors.

Korkmaz A, Ozlu T, Ozsu S, Kazaz Z, Bulbul Y.

Clin Appl Thromb Hemost. 2012 Jun;18(3):281-8. doi: 10.1177/1076029611431956. Epub 2012 Jan 23.

PMID:
22275389
34.

[Fondaparinux treatment in heparin induced thrombocytopenia:a case report].

Ozsu S, Korkmaz A, Bülbül Y, Oztuna F, Ozlü T.

Tuberk Toraks. 2011;59(2):178-83. Turkish.

35.

Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium.

Naas T, Bogaerts P, Kostyanev T, Cuzon G, Huang TD, Ozsu S, Nordmann P, Glupczynski Y.

J Antimicrob Chemother. 2011 Sep;66(9):2178-9. doi: 10.1093/jac/dkr252. Epub 2011 Jun 21. No abstract available.

PMID:
21693463
36.

Prognostic significance of PaO2/PaCO2 ratio in normotensive patients with pulmonary embolism.

Ozsu S, Abul Y, Yilmaz I, Ozsu A, Oztuna F, Bulbul Y, Ozlu T.

Clin Respir J. 2012 Apr;6(2):104-11. doi: 10.1111/j.1752-699X.2011.00253.x. Epub 2011 Jul 19.

PMID:
21651744
37.

C-reactive protein alone or combined with cardiac troponin T for risk stratification of respiratory intensive care unit patients.

Ozsu S, Yilmaz G, Yilmaz I, Oztuna F, Bulbul Y, Ozlu T.

Respir Care. 2011 Jul;56(7):1002-8. doi: 10.4187/respcare.01007. Epub 2011 Feb 21.

38.

An evaluation of the tuberculin skin test for anti TNF alpha prophylaxis in patients with ankylosing spondylitis and rheumatoid arthritis.

Karkucak M, Capkin E, Ozsu S, Nuhoglu I, Erol M, Yilmaz G, Gokmen F.

Bratisl Lek Listy. 2010;111(9):498-501.

PMID:
21180264
39.

Diagnostic value of pleural effusion ischaemia-modified albumin in patients with cardiac failure.

Ozsu S, Gulsoy A, Karahan SC, Mentese A, Nuhoglu I, Ozlu T.

Ann Clin Biochem. 2011 Jan;48(Pt 1):45-50. doi: 10.1258/acb.2010.010159. Epub 2010 Nov 29.

PMID:
21115570
40.

Combined risk stratification with computerized tomography /echocardiography and biomarkers in patients with normotensive pulmonary embolism.

Ozsu S, Karaman K, Mentese A, Ozsu A, Karahan SC, Durmus I, Oztuna F, Kosucu P, Bulbul Y, Ozlu T.

Thromb Res. 2010 Dec;126(6):486-92. doi: 10.1016/j.thromres.2010.08.021.

PMID:
20920821
41.

Elevated troponin T levels in massive pulmonary embolism without an abnormal D-dimer level.

Ozsu S, Yilmaz I, Bülbül Y, Oztuna F, Ozlu T.

J Emerg Med. 2012 Apr;42(4):460-1. doi: 10.1016/j.jemermed.2010.05.082. Epub 2010 Sep 15. No abstract available.

PMID:
20828973
42.

The role of risk factors in delayed diagnosis of pulmonary embolism.

Ozsu S, Oztuna F, Bulbul Y, Topbas M, Ozlu T, Kosucu P, Ozsu A.

Am J Emerg Med. 2011 Jan;29(1):26-32. doi: 10.1016/j.ajem.2009.07.005. Epub 2010 Mar 9.

PMID:
20825770
43.

Pulmonary atelectasis and survival in advanced non-small cell lung carcinoma.

Bulbul Y, Eris B, Orem A, Gulsoy A, Oztuna F, Ozlu T, Ozsu S.

Ups J Med Sci. 2010 Aug;115(3):176-80. doi: 10.3109/03009731003695624.

44.

[Pulmonary thromboembolism based on the Turkish national data].

Ozsu S, Ozlü T, Bülbül Y.

Tuberk Toraks. 2009;57(4):466-82. Review. Turkish.

PMID:
20037865
45.

An interesting cause of trauma: a ship's signal flare.

Tekinbas C, Erol MM, Gunduz A, Ozsu S, Oztuna F.

Wilderness Environ Med. 2009 Winter;20(4):391-2. doi: 10.1580/1080-6032-020.004.0391. No abstract available.

PMID:
20030452
46.

Giant fibrous tumor misdiagnosed as traumatic hemothorax.

Tekinbas C, Gunduz A, Turedi S, Erol MM, Ozsu S.

Acta Chir Belg. 2008 Nov-Dec;108(6):771-3. Review.

PMID:
19241939
47.

Meteorological parameters and seasonal variations in pulmonary thromboembolism.

Oztuna F, Ozsu S, Topbaş M, Bülbül Y, Koşucu P, Ozlü T.

Am J Emerg Med. 2008 Nov;26(9):1035-41. doi: 10.1016/j.ajem.2007.12.010.

PMID:
19091266
48.

Time delay between onset of symptoms and diagnosis in pulmonary thromboembolism.

Bulbul Y, Ozsu S, Kosucu P, Oztuna F, Ozlu T, Topbaş M.

Respiration. 2009;78(1):36-41. doi: 10.1159/000167409. Epub 2008 Oct 28.

PMID:
18957839
49.

Endobronchial metastasis from testicular seminoma.

Ozsu S, Erol MM, Oztuna F, Ersöz S, Kavgaci H, Aksoy HZ.

Med Princ Pract. 2008;17(6):493-5. doi: 10.1159/000151573. Epub 2008 Oct 3.

50.

Giant mass due to Castleman's disease causing superior vena cava syndrome.

Tekinbas C, Erol MM, Ozsu S, Cobanoglu U, Kosucu P.

Thorac Cardiovasc Surg. 2008 Aug;56(5):303-5. doi: 10.1055/s-2008-1038408.

PMID:
18615381

Supplemental Content

Support Center